Akiko Mizoguchi
Akiko Mizoguchi publishes mostly in Infectious Diseases, Pharmacology and Endocrinology, Diabetes and Metabolism, on topics such as Antimicrobial Resistance in Staphylococcus, Antibiotics Pharmacokinetics and Efficacy and Diabetes Management and Research.
- World rank
- #4,179,397 of 7,710,434 ranked researchers
- Rank in Japan
- #115,057 of 383,136
- Works
- 26
- Citations
- 447
- Citations per work
- 17.2
What does Akiko Mizoguchi research?
Akiko Mizoguchi's work is mostly in Medicine (49%), Psychology (4%), Biochemistry, Genetics and Molecular Biology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1348.9%
- Medicine1348.9%
- Everything else1244.8%
- Social Sciences13.8%
- Psychology13.8%
- Life Sciences12.5%
- 1Infectious Diseases15% of their works
- 2Pharmacology14% of their works
- 3Endocrinology, Diabetes and Metabolism14% of their works
- 4Epidemiology6% of their works
- 5Clinical Psychology4% of their works
- 6Molecular Biology2% of their works
Research topics
- Antimicrobial Resistance in Staphylococcus
- Antibiotics Pharmacokinetics and Efficacy
- Diabetes Management and Research
- Diabetes Treatment and Management
- Bacterial Identification and Susceptibility Testing
- Pharmacy and Medical Practices
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Sepsis Diagnosis and Treatment
Which keywords describe Akiko Mizoguchi's research?
The keywords of their largest research topics: Antimicrobial Resistance, Epidemiology, MRSA, Staphylococcus aureus, Antibiotic Pharmacokinetics, Critically Ill Patients, Glycemic Control and Insulin Therapy.
- Septic Shock
- Pharmaceutical Care
- Metabolic Syndrome
- Insulin Resistance
- Type 2 Diabetes
- Continuous Glucose Monitoring
- Diabetes
- Insulin Therapy
- Critically Ill Patients
- Staphylococcus aureus
- Epidemiology
- Antimicrobial Resistance
- MRSA
- Antibiotic Pharmacokinetics
- Glycemic Control
- Cardiovascular Disease
- Cardiovascular Outcomes
- Hypoglycemia
- Clinical Pharmacy
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- Microorganism Identification
- Sepsis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Antimicrobial Resistance212 topics
- Epidemiology132 topics
- MRSA111 topic
- Staphylococcus aureus111 topic
- Antibiotic Pharmacokinetics101 topic
- Critically Ill Patients101 topic
- Glycemic Control62 topics
- Insulin Therapy62 topics
- Cardiovascular Disease52 topics
- Diabetes52 topics
- Cardiovascular Outcomes31 topic
- Continuous Glucose Monitoring31 topic
- Hypoglycemia31 topic
- Type 2 Diabetes31 topic
- Clinical Pharmacy21 topic
- Insulin Resistance21 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry21 topic
- Metabolic Syndrome21 topic
- Microorganism Identification21 topic
- Pharmaceutical Care21 topic
- Sepsis21 topic
- Septic Shock21 topic
Where does Akiko Mizoguchi work?
Akiko Mizoguchi's main affiliation in the publication record is Sasebo City General Hospital, Japan.
How many publications and citations does Akiko Mizoguchi have?
OpenAlex counts 26 works and 447 citations for Akiko Mizoguchi, an h-index of 11, ranking #4,179,397 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Akiko Mizoguchi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.